Article Information
History
- December 8, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anton M. Sholukh1,*,#,
- Andrew Fiore-Gartland1,*,
- Emily S. Ford1,3,
- Yixuan J. Hou5,
- Victor Tse5,
- Hannah Kaiser7,
- Arnold Park7,
- Florian A. Lempp7,
- Russell Saint Germain1,
- Emily Bossard1,
- Jia Jin Kee1,
- Kurt Diem4,
- Andrew B. Stuart1,
- Peter B. Rupert2,
- Chance Brock2,
- Matthew Buerger2,
- Margaret K. Doll10,
- April Kaur Randhawa1,
- Leonidas Stamatatos1,
- Roland K. Strong1,2,
- Colleen McLaughlin10,
- Keith R. Jerome1,4,
- Ralph S. Baric5,6,
- David Montefiori8,9 and
- Lawrence Corey1,3,4,#
- 1Vaccine and Infectious Diseases Division, Fred Hutch Cancer Research Center, Seattle WA
- 2Basic Sciences Division, Fred Hutch Cancer Research Center, Seattle WA
- 3Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle WA
- 4Department of Laboratory Medicine and Pathology, University of Washington, Seattle WA
- 5Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC
- 6Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
- 7Vir Biotechnology, San Francisco, CA
- 8Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC
- 9Department of Surgery, Duke University, Durham, NC
- 10Department of Population Health Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY
- ↵#Address correspondence to Anton M. Sholukh, asholukh{at}fredhutch.org and Lawrence Corey, lcorey{at}fredhutch.org
↵* equal contribution
Posted December 08, 2020.
Evaluation of SARS-CoV-2 neutralization assays for antibody monitoring in natural infection and vaccine trials
